Evidence map›Paper›PMID 32732366›Full record

ArticleHaematologica2021

Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation.

Pierre-Edouard Debureaux, Pierre Bourrier, Pierre-Emmanuel Rautou, Anne-Marie Zagdanski, Morgane De Boutiny, Simona Pagliuca, Aurélien Sutra Del Galy, Marie Robin, Régis Peffault de Latour, Aurélie Plessier and 6 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Pierre-Edouard DebureauxHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
Pierre BourrierRadiology unit, Saint Louis Hospital, APHP, Paris, France.
Pierre-Emmanuel RautouDHU Unit, Pole des Maladies de Appareil Digestif, Service d'Hepatologie, Centre de Reference.
Anne-Marie ZagdanskiRadiology unit, Saint Louis Hospital, APHP, Paris, France.
Morgane De BoutinyRadiology unit, Saint Louis Hospital, APHP, Paris, France.
Simona PagliucaHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
Aurélien Sutra Del GalyHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
Marie RobinHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
Régis Peffault de LatourHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
Aurélie PlessierDHU Unit, Pole des Maladies Appareil Digestif, Service d'Hepatologie, Centre de Reference.
Flore Sicre de FontbruneHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
Aliénor XhaardHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
Pedro Henrique de Lima PrataHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
Dominique VallaDHU Unit, Pole des Maladies de Appareil Digestif, Service d'Hepatologie, Centre de Reference.
Gérard SociéHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
David MichonneauHematology and transplantation unit, Saint Louis Hospital, APHP, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRHôpital Saint-Louis · FRLaboratoire National de Référence · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant morbidity and mortality have been associated with liver complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Causes and consequences of these hepato-biliary complications are various and might be life-threatening. A high misdiagnosis rate has been reported because of a weak correlation between clinical, laboratory and imaging data. Liver elastography, a liver stiffness measure, is able to assess liver fibrosis and portal hypertension in most liver diseases, but data after allo-HSCT are scarce. Our aim was to determine the interest of sequential liver stiffness measurements for the diagnosis of early hepatic complications after allo-HSCT. Over a two years period of time, 161 consecutive adult patients were included and 146 were analyzed. Ultrasonography and elastography measurements were performed before transplantation, at day+7 and day+14 by three different experienced radiologists unaware of patients'clinical status. Eighty-one (55%) patients had liver involvements within the first 100 days after allo-HSCT. Baseline elastography was not predictive for the occurrence of overall liver abnormalities. A significant increase in 2D real-time shearwave elastography (2D-SWE) was found in patients with sinusoidal obstruction syndrome (SOS). Fifteen patients (10%) fulfilled EBMT score criteria and twelve (8%) reached Baltimore criteria for SOS diagnosis, but only six (4%) had a confirmed SOS. 2D-SWE at day+14 allowed early detection of SOS (AUROC=0.84, p=0.004) and improved sensibility (75%), specificity (99%) and positive predictive value (60%) over the Seattle, Baltimore or EBMT scores. A 2D-SWE measurement above 8.1kPa at day+14 after allo-HSCT seems a promising, non-invasive, and reproducible tool for early and accurate diagnosis of SOS.

Indexed as

Elasticity Imaging TechniquesHematopoietic Stem Cell TransplantationHepatic Veno-Occlusive DiseaseHumansLiverLiver Cirrhosis

Identifiers

PMID32732366
PMCPMC8409044
OpenAlexW3047238591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.